Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

[Image of the month. Pulmonary arteriovenous malformation: neonatal presentation of Rendu-Osler disease].

Van Kerkhoven C, El Abd K, Maton P, Brisbois D, Thimmesch M.

Rev Med Liege. 2019 Apr;74(4):173-174. French. No abstract available.

PMID:
30997964
2.

Healing Marginal Ulcers in Patients Who Have Had a Roux-en-Y Gastric Bypass.

Maton PN.

Clin Gastroenterol Hepatol. 2017 Sep;15(9):1482. doi: 10.1016/j.cgh.2017.04.029. Epub 2017 Apr 23. No abstract available.

PMID:
28442315
3.

Rigid catheters reduced duration of less invasive surfactant therapy procedures in manikins.

Rigo V, Debauche C, Maton P, Broux I, Van Laere D.

Acta Paediatr. 2017 Jul;106(7):1091-1096. doi: 10.1111/apa.13850. Epub 2017 May 2.

PMID:
28349627
4.

Guidelines for the Management of Extremely Premature Deliveries: A Systematic Review.

Guillén Ú, Weiss EM, Munson D, Maton P, Jefferies A, Norman M, Naulaers G, Mendes J, Justo da Silva L, Zoban P, Hansen TW, Hallman M, Delivoria-Papadopoulos M, Hosono S, Albersheim SG, Williams C, Boyle E, Lui K, Darlow B, Kirpalani H.

Pediatrics. 2015 Aug;136(2):343-50. doi: 10.1542/peds.2015-0542. Epub 2015 Jul 13. Review.

5.

Diagnostic pitfall in antenatal manifestations of CPT II deficiency.

Boemer F, Deberg M, Schoos R, Caberg JH, Gaillez S, Dugauquier C, Delbecque K, François A, Maton P, Demonceau N, Senterre G, Ferdinandusse S, Debray FG.

Clin Genet. 2016 Feb;89(2):193-7. doi: 10.1111/cge.12593. Epub 2015 May 5.

PMID:
25827434
6.

[Prostaglandins and the immune response at the intestinal submucosal level. A potential site for interference with the repeated use of paracetamol and ibuprofen at a young age?].

Langhendries JP, Maton P, François-Adant A, Chantrain C, Bury F, Philippet P.

Arch Pediatr. 2015 Mar;22(3):311-9. doi: 10.1016/j.arcped.2014.11.003. Epub 2014 Nov 15. French.

PMID:
25440768
7.

Optimizing Sedative Dose in Preterm Infants Undergoing Treatment for Respiratory Distress Syndrome.

Thall PF, Nguyen HQ, Zohar S, Maton P.

J Am Stat Assoc. 2014 Sep 1;109(507):931-943.

8.

[Use of therapeutic hypothermia in sudden unexpected postnatal collapse].

Cornet MC, Maton P, Langhendries JP, Marion W, Marguglio A, Smeets S, Vervoort A, François A.

Arch Pediatr. 2014 Sep;21(9):1006-10. doi: 10.1016/j.arcped.2014.06.009. Epub 2014 Jul 24. French.

PMID:
25089044
9.

Cost analysis of neonatal and pediatric parenteral nutrition in Europe: a multi-country study.

Walter E, Liu FX, Maton P, Storme T, Perrinet M, von Delft O, Puntis J, Hartigan D, Dragosits A, Sondhi S.

Eur J Clin Nutr. 2012 May;66(5):639-44. doi: 10.1038/ejcn.2011.225. Epub 2012 Jan 18.

PMID:
22252109
10.

[Implementation of the intestinal micro flora in the early stage and adequate immunity later on].

Langhendries JP, Maton P, François A, Marguglio A, Marion W, Smeets S, Philippet P.

Arch Pediatr. 2010 Sep;17 Suppl 3:S110-8. doi: 10.1016/S0929-693X(10)70910-6. French.

PMID:
20728810
11.

Pseudo-Bartter syndrome in a pregnant mother and her fetus.

Mathot M, Maton P, Henrion E, François-Adant A, Marguglio A, Gaillez S, Collard L, Langhendries JP.

Pediatr Nephrol. 2006 Jul;21(7):1037-40. Epub 2006 May 30.

PMID:
16773420
12.

Review article: prevention of stress-related mucosal bleeding with proton-pump inhibitors.

Maton PN.

Aliment Pharmacol Ther. 2005 Dec;22 Suppl 3:45-52. Review.

13.

Profile and assessment of GERD pharmacotherapy.

Maton PN.

Cleve Clin J Med. 2003 Nov;70 Suppl 5:S51-70. Review.

PMID:
14705381
14.

Safety and efficacy of long term esomeprazole therapy in patients with healed erosive oesophagitis.

Maton PN, Vakil NB, Levine JG, Hwang C, Skammer W, Lundborg P; Esomeprazole Study Investigators.

Drug Saf. 2001;24(8):625-35.

PMID:
11480494
15.

Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial.

Richter JE, Kahrilas PJ, Johanson J, Maton P, Breiter JR, Hwang C, Marino V, Hamelin B, Levine JG; Esomeprazole Study Investigators.

Am J Gastroenterol. 2001 Mar;96(3):656-65.

PMID:
11280530
16.

Salivary and gastric epidermal growth factor in patients with Zollinger-Ellison syndrome: its protective potential.

Sarosiek J, Jensen RT, Maton PN, Peura DA, Harlow D, Feng T, McCallum RW, Pisegna JR.

Am J Gastroenterol. 2000 May;95(5):1158-65.

PMID:
10811321
17.

Oral and intravenous dosage forms of pantoprazole are equivalent in their ability to suppress gastric acid secretion in patients with gastroesophageal reflux disease.

Metz DC, Pratha V, Martin P, Paul J, Maton PN, Lew E, Pisegna JR.

Am J Gastroenterol. 2000 Mar;95(3):626-33.

PMID:
10710049
18.

Antacids revisited: a review of their clinical pharmacology and recommended therapeutic use.

Maton PN, Burton ME.

Drugs. 1999 Jun;57(6):855-70. Review.

PMID:
10400401
19.
20.

Limp as unusual presentation of Langerhans' cell histiocytosis.

Bodart E, Nisolle JF, Maton P, Delos M, Trigaux JP, Gilliard C, Tuerlinckx D, Ninane J.

Eur J Pediatr. 1999 May;158(5):384-6.

PMID:
10333120
21.
22.

Use of granulocyte macrophage colony stimulating factor in children after orthotopic liver transplantation.

Trindade E, Maton P, Reding R, de Ville de Goyet J, Otte JB, Buts JP, Sokal EM.

J Hepatol. 1998 Jun;28(6):1054-7.

PMID:
9672183
23.

The impact of gastroesophageal reflux disease on health-related quality of life.

Revicki DA, Wood M, Maton PN, Sorensen S.

Am J Med. 1998 Mar;104(3):252-8.

PMID:
9552088
24.

Meal type affects heartburn severity.

Rodriguez S, Miner P, Robinson M, Greenwood B, Maton PN, Pappa K.

Dig Dis Sci. 1998 Mar;43(3):485-90.

PMID:
9539641
25.

Effects of oral rabeprazole on oesophageal and gastric pH in patients with gastro-oesophageal reflux disease.

Robinson M, Maton PN, Rodriguez S, Greenwood B, Humphries TJ.

Aliment Pharmacol Ther. 1997 Oct;11(5):973-80.

26.
27.

Irritable bowel syndrome: a study to investigate the mechanism(s) of visceral hypersensitivity.

Greenwood B, Rodriguez S, Decktor D, Maton PN, Robinson M.

J Okla State Med Assoc. 1996 Feb;89(2):47-50.

PMID:
8907258
28.

Effects of Aluminum/Magnesium Hydroxide and Calcium Carbonate on Esophageal and Gastric pH in Subjects with Heartburn.

Decktor DL, Robinson M, Maton PN, Lanza FL, Gottlieb S.

Am J Ther. 1995 Aug;2(8):546-552.

PMID:
11854825
29.

Somatostatin receptor subtype 3 mediates the inhibitory action of somatostatin on gastric smooth muscle cells.

Gu ZF, Corleto VD, Mantey SA, Coy DH, Maton PN, Jensi RT.

Am J Physiol. 1995 May;268(5 Pt 1):G739-48.

PMID:
7762657
30.

Pathophysiological effects of long-term acid suppression in man.

McCloy RF, Arnold R, Bardhan KD, Cattan D, Klinkenberg-Knol E, Maton PN, Riddell RH, Sipponen P, Walan A.

Dig Dis Sci. 1995 Feb;40(2 Suppl):96S-120S. Review.

PMID:
7859587
31.

Comment on the paper by Waldum et al. Risks of hypergastrinemia.

Maton P.

Dig Dis. 1995 Jan-Feb;13(1):1-2. No abstract available.

PMID:
7606833
32.

Management of Zollinger-Ellison syndrome.

Maton PN.

Gastroenterologist. 1994 Jun;2(2):111-8. Review.

PMID:
8055236
33.

Expanding uses of octreotide.

Maton PN.

Baillieres Clin Gastroenterol. 1994 Jun;8(2):321-37. Review.

PMID:
7949461
34.

Review article: the management of Zollinger-Ellison syndrome.

Maton PN.

Aliment Pharmacol Ther. 1993 Oct;7(5):467-75. Review.

PMID:
7904187
35.

Use of octreotide acetate for control of symptoms in patients with islet cell tumors.

Maton PN.

World J Surg. 1993 Jul-Aug;17(4):504-10. Review.

PMID:
8395751
36.

Omeprazole is superior to ranitidine plus metoclopramide in the short-term treatment of erosive oesophagitis.

Robinson M, Decktor DL, Maton PN, Sabesin S, Roufail W, Kogut D, Roberts W, McCullough A, Pardoll P, Saco L, et al.

Aliment Pharmacol Ther. 1993 Feb;7(1):67-73.

PMID:
8439639
37.

Prospective study of efficacy and safety of lansoprazole in Zollinger-Ellison syndrome.

Metz DC, Pisegna JR, Ringham GL, Feigenbaum K, Koviack PD, Maton PN, Gardner JD, Jensen RT.

Dig Dis Sci. 1993 Feb;38(2):245-56.

38.
39.

Hemihypertrophy, bilateral Wilms' tumor, and clear-cell adenocarcinoma of the uterine cervix in a young girl.

Stalens JP, Maton P, Gosseye S, Clapuyt P, Ninane J.

Med Pediatr Oncol. 1993;21(9):671-5.

PMID:
8413002
40.

Stereologic investigations of human gastric mucosa. II. Oxyntic mucosa from patients with Zollinger-Ellison syndrome.

Helander HF, Rutgersson K, Helander KG, Pisegna JP, Gardner JD, Jensen RT, Maton PN.

Scand J Gastroenterol. 1992 Oct;27(10):875-83.

PMID:
1439541
41.

Use of gut peptide receptor agonists and antagonists in gastrointestinal diseases.

Maton PN, Jensen RT.

Gastroenterol Clin North Am. 1992 Sep;21(3):551-66. Review.

PMID:
1355466
42.
43.

Interaction of calcitonin gene-related peptides with pancreatic acinar cells and dispersed gastric smooth muscle cells.

Jensen RT, Zhou ZC, Gu ZF, Kitsukawa Y, Honda T, Maton PN.

Ann N Y Acad Sci. 1992 Jun 30;657:268-88. Review. No abstract available.

PMID:
1379015
44.

Effects of curative gastrinoma resection on gastric secretory function and antisecretory drug requirement in the Zollinger-Ellison syndrome.

Pisegna JR, Norton JA, Slimak GG, Metz DC, Maton PN, Gardner JD, Jensen RT.

Gastroenterology. 1992 Mar;102(3):767-78.

PMID:
1537514
45.

Actions of somatostatins on gastric smooth muscle cells.

Gu ZF, Pradhan T, Coy DH, Mantey S, Bunnett NW, Jensen RT, Maton PN.

Am J Physiol. 1992 Mar;262(3 Pt 1):G432-8.

PMID:
1347975
46.

Characterization of opioid receptors on smooth muscle cells from guinea pig stomach.

Zhang L, Gu ZF, Pradhan T, Jensen RT, Maton PN.

Am J Physiol. 1992 Mar;262(3 Pt 1):G461-9.

PMID:
1312793
47.

Zollinger-Ellison syndrome: technique, results, and complications of portal venous sampling.

Miller DL, Doppman JL, Metz DC, Maton PN, Norton JA, Jensen RT.

Radiology. 1992 Jan;182(1):235-41.

PMID:
1727289
48.

Effect of different doses of omeprazole on 24-hour oesophageal acid exposure in patients with gastro-oesophageal reflux.

Robinson M, Maton PN, Allen ML, Humphries TJ, McIntosh D, Cagliola AJ, Bradstreet TE.

Aliment Pharmacol Ther. 1991 Dec;5(6):645-51.

PMID:
1782307
49.

Inhibition of peptidases potentiates enkephalin-stimulated contraction of gastric muscle cells.

Menozzi D, Gu ZF, Maton PN, Bunnett NW.

Am J Physiol. 1991 Sep;261(3 Pt 1):G476-84.

PMID:
1679601
50.

Pharmacokinetics of oral and intravenous omeprazole in patients with the Zollinger-Ellison syndrome.

Vinayek R, Amantea MA, Maton PN, Frucht H, Gardner JD, Jensen RT.

Gastroenterology. 1991 Jul;101(1):138-47.

PMID:
2044903

Supplemental Content

Support Center